Instructions for Serralizin capsules No. 30
Composition
1 capsule contains methylsulfonylmethane - 400 mg (mg), serratiopeptidase enzyme - 10 mg (mg)
Excipients: microcrystalline cellulose, potato starch, calcium stearate, silicon dioxide (orysil)
Capsule shell: gelatin
General properties
Serratiopeptidase, which is part of the composition, is a proteolytic enzyme isolated from the non-pathogenic intestinal bacterium Serratia E15. It has fibrinolytic, anti-inflammatory and anti-edematous activity. In addition to reducing the inflammatory process, serratiopeptidase helps to relieve pain by blocking the release of pain amines from inflamed tissues. Serratiopeptidase binds in a 1:1 ratio to blood alpha-2-macroglobulin, which masks its antigenicity, but retains its enzymatic activity. Then, gradually at the site of inflammation, it turns into exudate and, accordingly, its level in the blood decreases. Serratiopeptidase directly reduces dilatation (expansion) of capillaries and controls their permeability due to the hydrolysis of bradykinin, histamine and serotonin. Serratiopeptidase also blocks plasmin inhibitors, thus contributing to the fibrinolytic activity of plasmin. By reducing swelling and improving microcirculation, serratiopeptidase promotes sputum secretion.
The enzymatic activity of Serratiopeptidase is 10 times higher than that of α-chymotrypsin. It very effectively hydrolyzes inflammatory mediators of polypeptide nature (bradykinin, etc.), fibrin, but has no significant effect on proteins of a living organism, such as albumin and α- and γ-globulin. Serratiopeptidase does not break down fibrinogen, therefore it has no significant effect on blood clotting processes. Serratiopeptidase penetrates well into areas of inflammation, lyses necrotic tissues and their decomposition products, reduces hyperemia and accelerates the penetration and activity of antibiotics. Serratiopeptidase reduces the viscosity of saliva and nasal secretions, thereby facilitating their removal.
Methylsulfonylmethane has anti-inflammatory properties, which make it effective in purulent-inflammatory processes of any localization, has reparative properties, which accelerates regeneration. Methylsulfonylmethane enhances the anti-inflammatory effect of Serratiopeptidase.
Serratiopeptidase and methylsulfonylmethane may be recommended for:
Surgical diseases accompanied by inflammation, swelling and pain
Traumatic diseases: fractures, dislocations, arthritis, arthrosis, ligament ruptures, etc.
Upper respiratory tract diseases: to reduce swelling, inflammation, sputum viscosity and facilitate its discharge from the respiratory tract
Diseases of the ENT organs: to reduce swelling, inflammation, and facilitate the discharge of secretions from the paranasal sinuses
Skin diseases: acute inflammatory dermatoses
Diseases of the female genital organs: inflammatory diseases of the pelvic organs, inflammatory diseases of the mammary glands
Urological diseases accompanied by inflammation
Recommendations for use
May be recommended by a doctor as an additional source of serratiopeptidase (enzymes) and methylsulfonylmethane.
Method of administration and doses
The capsule is taken orally after meals, swallowed whole, without chewing, with sufficient liquid, 1 capsule 2 times a day. The dose and duration of the course of administration depend on the nature and dynamics of the process and are determined in each case individually by the doctor.
Reservation
With individual sensitivity to the components of the supplement, pregnancy and breastfeeding, children's age, blood clotting disorders. Do not exceed the recommended amount (serving) for daily consumption. Should not be used as a substitute for a full diet. Before use, consultation with a doctor is recommended.
Release form
Capsule net weight 470 mg ± 7%
Expiration date
24 months from date of manufacture. The batch number and expiration date are indicated on the packaging.
Storage conditions
Store in a dry place, protected from sunlight, out of the reach of children, in a tightly closed package, at a temperature not exceeding 25 ° C.
Dietary supplement. Not a medicine. Does not contain GMOs.
TU U 10.8-44571792-001:2021
Packaging
10 capsules in a blister, 3 blisters in a package.
Producer
LLC "Nutrimed", 03150, Ukraine, Kyiv, Predslavynska St. 43/2.
Address of production facilities: Ukraine, 20741, Cherkasy region, Cherkasy district, village Sunky, Centralna st., 1
To order: LLC "GROV FARM", Kyiv, Stepana Bandera Avenue, 6
